Tsumura & Co. (4540.T)
JPY 4759.0
(-0.69%)
JPY 4759.0
(-0.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 150.84 Billion JPY | 7.71% |
| 2022 | 140.04 Billion JPY | 8.1% |
| 2021 | 129.54 Billion JPY | -1.02% |
| 2020 | 130.88 Billion JPY | 6.19% |
| 2019 | 123.24 Billion JPY | 1.94% |
| 2018 | 120.9 Billion JPY | 2.57% |
| 2017 | 117.88 Billion JPY | 2.54% |
| 2016 | 114.95 Billion JPY | 2.08% |
| 2015 | 112.61 Billion JPY | 1.97% |
| 2014 | 110.43 Billion JPY | 0.35% |
| 2013 | 110.05 Billion JPY | 4.18% |
| 2012 | 105.63 Billion JPY | 10.67% |
| 2011 | 95.45 Billion JPY | 0.71% |
| 2010 | 94.77 Billion JPY | 4.23% |
| 2009 | 90.93 Billion JPY | 1.01% |
| 2008 | 90.02 Billion JPY | -5.04% |
| 2007 | 94.8 Billion JPY | 3.89% |
| 2006 | 91.25 Billion JPY | 0.91% |
| 2005 | 90.42 Billion JPY | 6.6% |
| 2004 | 84.82 Billion JPY | 3.26% |
| 2003 | 82.14 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 43.69 Billion JPY | 24.76% |
| 2023 Q1 | 37.03 Billion JPY | 12.34% |
| 2023 Q4 | 35.01 Billion JPY | -13.58% |
| 2023 FY | 150.84 Billion JPY | 7.71% |
| 2023 Q3 | 40.52 Billion JPY | 5.9% |
| 2023 Q2 | 38.26 Billion JPY | 3.32% |
| 2022 Q3 | 36.96 Billion JPY | 3.58% |
| 2022 FY | 140.04 Billion JPY | 8.1% |
| 2022 Q1 | 34.41 Billion JPY | 10.44% |
| 2022 Q2 | 35.69 Billion JPY | 3.7% |
| 2022 Q4 | 32.96 Billion JPY | -10.83% |
| 2021 Q4 | 31.16 Billion JPY | -10.87% |
| 2021 FY | 129.54 Billion JPY | -1.02% |
| 2021 Q1 | 31.77 Billion JPY | 1.18% |
| 2021 Q2 | 31.64 Billion JPY | -0.4% |
| 2021 Q3 | 34.96 Billion JPY | 10.49% |
| 2020 Q4 | 31.39 Billion JPY | -11.52% |
| 2020 Q1 | 31.76 Billion JPY | 13.2% |
| 2020 Q2 | 32.22 Billion JPY | 1.44% |
| 2020 Q3 | 35.48 Billion JPY | 10.12% |
| 2020 FY | 130.88 Billion JPY | 6.19% |
| 2019 Q3 | 34.38 Billion JPY | 14.22% |
| 2019 FY | 123.24 Billion JPY | 1.94% |
| 2019 Q1 | 30.69 Billion JPY | 6.24% |
| 2019 Q2 | 30.1 Billion JPY | -1.94% |
| 2019 Q4 | 28.06 Billion JPY | -18.38% |
| 2018 Q2 | 28.49 Billion JPY | -4.31% |
| 2018 Q3 | 33.74 Billion JPY | 18.43% |
| 2018 Q4 | 28.89 Billion JPY | -14.36% |
| 2018 Q1 | 29.77 Billion JPY | 10.4% |
| 2018 FY | 120.9 Billion JPY | 2.57% |
| 2017 Q3 | 32.62 Billion JPY | 11.69% |
| 2017 Q2 | 29.21 Billion JPY | 0.5% |
| 2017 Q4 | 26.97 Billion JPY | -17.34% |
| 2017 Q1 | 29.06 Billion JPY | 7.67% |
| 2017 FY | 117.88 Billion JPY | 2.54% |
| 2016 FY | 114.95 Billion JPY | 2.08% |
| 2016 Q2 | 27.66 Billion JPY | -3.57% |
| 2016 Q3 | 31.6 Billion JPY | 14.22% |
| 2016 Q4 | 26.99 Billion JPY | -14.56% |
| 2016 Q1 | 28.69 Billion JPY | 10.12% |
| 2015 FY | 112.61 Billion JPY | 1.97% |
| 2015 Q4 | 26.05 Billion JPY | -18.58% |
| 2015 Q2 | 27.8 Billion JPY | 3.89% |
| 2015 Q3 | 32 Billion JPY | 15.12% |
| 2015 Q1 | 26.76 Billion JPY | 5.25% |
| 2014 Q4 | 25.42 Billion JPY | -21.3% |
| 2014 Q1 | 26.62 Billion JPY | -2.93% |
| 2014 Q2 | 26.08 Billion JPY | -2.05% |
| 2014 FY | 110.43 Billion JPY | 0.35% |
| 2014 Q3 | 32.3 Billion JPY | 23.86% |
| 2013 Q4 | 27.43 Billion JPY | -6.15% |
| 2013 FY | 110.05 Billion JPY | 4.18% |
| 2013 Q1 | 26.49 Billion JPY | 5.17% |
| 2013 Q2 | 26.9 Billion JPY | 1.52% |
| 2013 Q3 | 29.22 Billion JPY | 8.65% |
| 2012 Q1 | 26.03 Billion JPY | 16.31% |
| 2012 Q4 | 25.19 Billion JPY | -14.28% |
| 2012 Q2 | 25.01 Billion JPY | -3.91% |
| 2012 Q3 | 29.39 Billion JPY | 17.51% |
| 2012 FY | 105.63 Billion JPY | 10.67% |
| 2011 Q4 | 22.38 Billion JPY | -17.73% |
| 2011 FY | 95.45 Billion JPY | 0.71% |
| 2011 Q1 | 24.36 Billion JPY | 4.43% |
| 2011 Q3 | 27.2 Billion JPY | 26.58% |
| 2011 Q2 | 21.49 Billion JPY | -11.8% |
| 2010 Q1 | 22.95 Billion JPY | 12.1% |
| 2010 Q3 | 26.06 Billion JPY | 16.27% |
| 2010 Q4 | 23.33 Billion JPY | -10.48% |
| 2010 FY | 94.77 Billion JPY | 4.23% |
| 2010 Q2 | 22.42 Billion JPY | -2.33% |
| 2009 FY | 90.93 Billion JPY | 1.01% |
| 2009 Q4 | 20.47 Billion JPY | -21.05% |
| 2009 Q3 | 25.93 Billion JPY | 17.9% |
| 2009 Q2 | 21.99 Billion JPY | -2.35% |
| 2009 Q1 | 22.52 Billion JPY | 7.48% |
| 2008 Q4 | 20.95 Billion JPY | -14.97% |
| 2008 Q2 | 20.8 Billion JPY | 0.0% |
| 2008 FY | 90.02 Billion JPY | -5.04% |
| 2008 Q3 | 24.64 Billion JPY | 18.46% |
| 2007 FY | 94.8 Billion JPY | 3.89% |
| 2006 FY | 91.25 Billion JPY | 0.91% |
| 2005 FY | 90.42 Billion JPY | 6.6% |
| 2004 FY | 84.82 Billion JPY | 3.26% |
| 2003 FY | 82.14 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -142.723% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 96.462% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 52.045% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 65.329% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -1849.298% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -1.747% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -109.379% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 79.664% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -1115.904% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -6.449% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -46.615% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -172.254% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -390.585% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -99.586% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -176.081% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 33.821% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -268.913% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -99.201% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -26.196% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -2892.956% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -221.665% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -2598.62% |
| MedRx Co., Ltd | 26 Million JPY | -580073.077% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -1272.599% |
| Solasia Pharma K.K. | 617 Million JPY | -24348.136% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -140.035% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 14.71% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -246733.682% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 89.785% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -581.504% |